Advertisement
Advertisement
U.S. Markets open in 53 mins
Advertisement
Advertisement
Advertisement
Advertisement

IM Cannabis Corp. (IMCC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
3.9500-0.0400 (-1.00%)
At close: 3:59PM EST
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.9900
Open3.9800
Bid3.8200 x N/A
Ask3.9800 x N/A
Day's Range3.7500 - 3.9900
52 Week Range2.8400 - 14.4000
Volume62,106
Avg. Volume46,127
Market Cap225.417M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.7710
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction

    TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 18, 2021 /IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Germany and Canada, today announced the fourth installment of shares in connection with the previously announced acquisition of the Panaxia-to-the-Home online pharmacy and trading centre with an IMC-GDP license from Panaxia Pharmaceutical Industries Israel Ltd.

  • ACCESSWIRE

    IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update

    4 million; a 30% increase from Q2 2021Gross margin improved to 20% from 5.4% in Q2 2021; expected to increase further in Q4 and into 2022Canadian recreational brands WAGNERS and Highland Grow continue to gain market share, with sales in Ontario from June to October increasing by over 110%TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 15, 2021 / IM Cannabis Corp.

  • TipRanks

    2 ‘Underfollowed’ Cannabis Stocks Gearing up for Gains; Analyst Says ‘Buy’

    Last year, the Democratic Party won a major electoral victory at the upper Federal levels, taking control of the White House and the US Senate, while retaining control of the House of Representatives. Their control of Congress rests on thin margins – but it is a legislative majority, and it held out high hopes of real policy shifts from the Trump Administration. Cannabis investors, especially, were pleased, as the Democrats are seen as far more likely to legalize the substance at the Federal lev

Advertisement
Advertisement